Opinion | ‘The FDA Is Rarely That Clear’: What We Heard This Week
“The FDA is rarely that clear, so this is refreshing.” — Paul Knoepfler, PhD, of the University of California Davis, on the FDA getting tougher on birth tissue injection companies, following a recent warning letter to one company in question. “Everyone is at risk.” — Ziyad Al-Aly, MD, of Washington University in St. Louis, on […]